The FDA has given Varian Medical Systems 510(k) clearance for a new version of the company's Vitesse system, which allows doctors to plan high-dose-rate brachytherapy for prostate cancer patients in real time. The FDA also has cleared the company's Edge radiosurgery system, which comes with motion management and real-time tumor tracking tools.
FDA gives Varian Medical nod on 2 cancer therapy systems
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||